Yanwei Luo Selected Research

Yanwei Luo Research Topics

Disease

16	Neoplasms (Cancer) 01/2023 - 01/2015
7	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2015
4	Nasopharyngeal Carcinoma 01/2022 - 08/2017
4	Neoplasm Metastasis (Metastasis) 09/2020 - 02/2017
3	Squamous Cell Carcinoma of Head and Neck 05/2023 - 01/2020
3	Multiple Myeloma 11/2020 - 01/2019
2	Carcinogenesis 12/2023 - 08/2017
2	Testicular Germ Cell Tumor 05/2023 - 01/2022
2	Acute Lung Injury 06/2022 - 01/2018
2	Lymphatic Metastasis 01/2018 - 04/2016
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2024
1	Seminoma 12/2023
1	Osteosarcoma (Osteogenic Sarcoma) 05/2023
1	Stomach Neoplasms (Stomach Cancer) 05/2023
1	Lung Injury 06/2022
1	Rhabdomyosarcoma 01/2022
1	Ovarian Epithelial Carcinoma 09/2020
1	Ovarian Neoplasms (Ovarian Cancer) 09/2020
1	Lentivirus Infections 01/2020
1	Colonic Neoplasms (Colon Cancer) 01/2020
1	Diabetes Mellitus 01/2020
1	Myocardial Infarction 01/2019
1	Hepatocellular Carcinoma (Hepatoma) 01/2019
1	Lung Neoplasms (Lung Cancer) 01/2018
1	Cerebral Infarction 03/2016
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 03/2016
1	Neurodevelopmental Disorders 06/2015

Drug/Important Bio-Agent (IBA)

9	Biomarkers (Surrogate Marker)IBA 05/2023 - 01/2015
7	Proteins (Proteins, Gene)FDA Link 06/2022 - 06/2015
6	Long Noncoding RNAIBA 05/2023 - 08/2017
6	Circular RNAIBA 12/2020 - 01/2019
4	Paclitaxel (Taxol)FDA LinkGeneric 03/2019 - 01/2015
3	RNA (Ribonucleic Acid)IBA 09/2020 - 02/2017
3	Sincalide FDA Link 09/2020 - 01/2019
2	LipopolysaccharidesIBA 06/2022 - 01/2018
2	Untranslated RNA (Noncoding RNA)IBA 01/2022 - 02/2017
2	Bortezomib (Velcade)FDA Link 11/2020 - 01/2019
2	LuciferasesIBA 09/2020 - 01/2019
2	Cisplatin (Platino)FDA LinkGeneric 09/2020 - 01/2019
2	Miat long non-coding RNAIBA 01/2019 - 01/2018
2	Small Interfering RNA (siRNA)IBA 01/2018 - 01/2015
1	DNA (Deoxyribonucleic Acid)IBA 01/2023
1	Competitive Endogenous RNAIBA 01/2023
1	Carrier Proteins (Binding Protein)IBA 06/2022
1	Interleukin-6 (Interleukin 6)IBA 06/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2022
1	Phosphotransferases (Kinase)IBA 06/2022
1	Caspase 8 (Caspase-8)IBA 06/2022
1	Caspase 3 (Caspase-3)IBA 06/2022
1	Z-Form DNA (Z-DNA)IBA 06/2022
1	CollagenIBA 01/2022
1	UbiquitinIBA 01/2022
1	Nuclear RNAIBA 01/2022
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2022
1	5-ethynyl-2'-deoxyuridineIBA 09/2020
1	Capecitabine (Xeloda)FDA Link 01/2020
1	ChromatinIBA 01/2020
1	Insulin (Novolin)FDA Link 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	Messenger RNA (mRNA)IBA 03/2019
1	Pyruvic Acid (Pyruvate)IBA 03/2019
1	Lactic Acid (Lactate)FDA LinkGeneric 03/2019
1	EnzymesIBA 03/2019
1	Lactate Dehydrogenase 5IBA 03/2019
1	mouse MIRN29 microRNAIBA 01/2019
1	Proteasome InhibitorsIBA 01/2019
1	Cyclin D1IBA 01/2018
1	Gefitinib (Iressa)FDA Link 01/2018
1	ParaffinIBA 02/2017
1	MicroRNAs (MicroRNA)IBA 02/2017
1	I-kappa B KinaseIBA 04/2016
1	salicylhydroxamic acid (SHAM)IBA 03/2016
1	triphenyltetrazoliumIBA 03/2016
1	Phenobarbital (Luminal)FDA Link 01/2015
1	bcl-2 Homologous Antagonist-Killer Protein (bcl 2 Homologous Antagonist Killer Protein)IBA 01/2015

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 01/2024 - 01/2020
2	Immunotherapy 01/2024 - 01/2022
1	Therapeutics 12/2023
1	Intraperitoneal Injections 01/2018
1	Neoadjuvant Therapy 02/2017